Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 54.43B | 54.78B | 53.31B | 51.06B | 46.89B | 46.70B |
Gross Profit | 21.32B | 22.38B | 20.70B | 16.77B | 15.79B | 18.01B |
EBITDA | 15.35B | 16.09B | 15.23B | 11.58B | 10.79B | 13.09B |
Net Income | 7.46B | 7.83B | 7.01B | 4.94B | 4.49B | 6.09B |
Balance Sheet | ||||||
Total Assets | 47.78B | 52.11B | 53.92B | 53.54B | 48.78B | 53.32B |
Cash, Cash Equivalents and Short-Term Investments | 10.95B | 15.58B | 16.86B | 16.92B | 12.27B | 17.74B |
Total Debt | 22.02B | 28.10B | 29.72B | 34.15B | 29.83B | 33.19B |
Total Liabilities | 43.60B | 44.70B | 47.00B | 48.51B | 43.06B | 47.62B |
Stockholders Equity | 4.18B | 7.41B | 6.92B | 5.03B | 5.72B | 5.81B |
Cash Flow | ||||||
Free Cash Flow | 7.32B | 8.10B | 11.08B | 6.18B | 4.65B | 9.52B |
Operating Cash Flow | 9.49B | 10.60B | 12.76B | 8.32B | 6.80B | 10.33B |
Investing Cash Flow | -598.89M | -1.30B | -311.39M | -2.15B | -2.14B | -795.28M |
Financing Cash Flow | -14.87B | -13.50B | -9.83B | -1.32B | -11.07B | 2.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $143.20B | 23.92 | 28.36% | 3.39% | -0.30% | -14.60% | |
69 Neutral | $21.93B | 42.46 | 12.07% | 1.33% | 1.13% | -34.78% | |
66 Neutral | $6.24B | 16.73 | 142.03% | 5.12% | -11.23% | -17.45% | |
63 Neutral | $63.94B | 22.24 | 705.21% | 2.62% | 0.05% | 3.55% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $14.74B | 18.49 | 249.61% | 4.08% | 0.16% | 191.17% | |
57 Neutral | $40.59B | 16.86 | 196.26% | 4.18% | -6.89% | 7.52% |